We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Monitoring ANCA Levels Helps Predict Relapse of Systemic Vasculitis in Patients with Kidney Involvement

By LabMedica International staff writers
Posted on 28 Oct 2014
Repeated measurement of levels of anti-neutrophil cytoplasmic antibodies (ANCA) predicts likelihood of relapse in patients suffering from systemic vasculitis with kidney involvement.

Anti-neutrophil cytoplasmic antibodies are a group of autoantibodies, mainly of the IgG type, against antigens in the cytoplasm of neutrophil granulocytes (the most common type of white blood cell) and monocytes. They are detected by a blood test in a number of autoimmune disorders, but are particularly associated with systemic vasculitis. The antibodies produced by patients with ANCA-associated vasculitis can damage blood vessels, and relapses of the disorder can cause severe and permanent damage to organs and other parts of the body.

Although the value of measuring ANCA during follow-up to predict a relapse has been controversial, investigators at Maastricht University (The Netherlands) postulated that measuring ANCA could be useful in patients with renal involvement but would be less valuable in patients with non-renal disease.

To test this theory, they monitored PR3-ANCA and MPO-ANCA levels in 166 consecutive patients with ANCA-associated vasculitis who were positive for either proteinase 3 (PR3)-ANCA or myeloperoxidase (MPO)-ANCA. Among the study group were 104 patients with kidney problems associated with the disease and 62 without.

During the follow-up period that averaged 49 months and included an average of 18 additional ANCA measurements, increase in ANCA levels was seen in 89 patients and 74 relapses were recorded. ANCA rises correlated with relapses in patients who presented with renal involvement but in comparison, associated only weakly with relapses in patients who presented with non-renal disease.

“By measuring ANCA levels in patients with kidney involvement, doctors can predict which patients are going to relapse. It is expected that by using ANCAs as a guideline, severe relapses necessitating dialysis can be prevented,” said senior author Dr. Jan Willem Cohen Tervaert, professor of medicine and immunology at Maastricht University.

The study was published in the October 16, 2014, online edition of the Journal of the American Society of Nephrology.

Related Links:

Maastricht University



Gold Member
Troponin T QC
Troponin T Quality Control
Verification Panels for Assay Development & QC
Seroconversion Panels
New
H.pylori Test
Humasis H.pylori Card
New
Mycoplasma Pneumoniae Virus Test
Mycoplasma Pneumoniae Virus Detection Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get complete access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The experimental blood test accurately indicates severity and predicts potential recovery from spinal cord injury (Photo courtesy of 123RF)

Blood Test Identifies Multiple Biomarkers for Rapid Diagnosis of Spinal Cord Injury

The National Institutes of Health estimates that 18,000 individuals in the United States sustain spinal cord injuries (SCIs) annually, resulting in a staggering financial burden of over USD 9.... Read more

Microbiology

view channel
Image: Schematic representation illustrating the key findings of the study (Photo courtesy of UNIST)

Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours

Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read more

Industry

view channel
Image: Tumor-associated macrophages visualized using the Multiomic LS Assay (Photo courtesy of ACD)

Leica Biosystems and Bio-Techne Expand Spatial Multiomic Collaboration

Bio-Techne Corporation (Minneapolis, MN, USA) has expanded the longstanding partnership between its spatial biology brand, Advanced Cell Diagnostics (ACD, Newark, CA, USA), and Leica Biosystems (Nussloch,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.